Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

https://www.ci-3.de

The CI3 excellence cluster pools the outstanding expertise in the Rhine-Main cluster region of Germany involving innovative new therapies and diagnostics in the field of individualised immune intervention. To this end, CI3 is putting together a network of players from the business, research and healthcare communities as well as government and is shaping the integral element across the entire innovation and value creation chain. *

	Start	2011-04-14 existent
	Industry	pharmacogenomics/pharmacogenetics
	Person	Türeci, Özlem (BioNtech 202208 CMO formerly Ganymed 200811 CEO + CSO)
	Person 2	Wessel, Rainer (DKFZ 201906– before CI3 Cluster Manager before Ganymed CEO)

	Region	Mainz
	Country	Germany
	Street	17–19 Kupferbergterrasse
	City	55116 Mainz
	Tel	+49-6131-6230581
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.)

[1] Cluster für Individualisierte ImmunIntervention (Ci3) e. V.. (8/1/17). "Press Release: Collaboration Project between German Biotech and IT Companies Selected for Funding in First PERMIDES Round of Call"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]